Hologic Statistics
Total Valuation
Hologic has a market cap or net worth of $14.20 billion. The enterprise value is $14.76 billion.
| Market Cap | 14.20B |
| Enterprise Value | 14.76B |
Important Dates
The last earnings date was Wednesday, February 5, 2025, after market close.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Hologic has 224.39 million shares outstanding. The number of shares has decreased by -4.48% in one year.
| Current Share Class | 224.39M |
| Shares Outstanding | 224.39M |
| Shares Change (YoY) | -4.48% |
| Shares Change (QoQ) | -1.64% |
| Owned by Insiders (%) | 0.82% |
| Owned by Institutions (%) | 103.76% |
| Float | 222.27M |
Valuation Ratios
The trailing PE ratio is 20.05 and the forward PE ratio is 14.57. Hologic's PEG ratio is 1.74.
| PE Ratio | 20.05 |
| Forward PE | 14.57 |
| PS Ratio | 3.66 |
| Forward PS | 3.37 |
| PB Ratio | 2.99 |
| P/TBV Ratio | 25.48 |
| P/FCF Ratio | 12.56 |
| P/OCF Ratio | 11.32 |
| PEG Ratio | 1.74 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.54, with an EV/FCF ratio of 13.05.
| EV / Earnings | 19.84 |
| EV / Sales | 3.65 |
| EV / EBITDA | 11.54 |
| EV / EBIT | 15.10 |
| EV / FCF | 13.05 |
Financial Position
The company has a current ratio of 3.49, with a Debt / Equity ratio of 0.53.
| Current Ratio | 3.49 |
| Quick Ratio | 2.60 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 1.92 |
| Debt / FCF | 2.25 |
| Interest Coverage | 7.72 |
Financial Efficiency
Return on equity (ROE) is 15.78% and return on invested capital (ROIC) is 8.40%.
| Return on Equity (ROE) | 15.78% |
| Return on Assets (ROA) | 7.10% |
| Return on Invested Capital (ROIC) | 8.40% |
| Return on Capital Employed (ROCE) | 12.65% |
| Revenue Per Employee | $577,825 |
| Profits Per Employee | $106,438 |
| Employee Count | 6,990 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.35 |
Taxes
In the past 12 months, Hologic has paid $177.30 million in taxes.
| Income Tax | 177.30M |
| Effective Tax Rate | 19.24% |
Stock Price Statistics
The stock price has decreased by -14.09% in the last 52 weeks. The beta is 0.97, so Hologic's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -14.09% |
| 50-Day Moving Average | 69.14 |
| 200-Day Moving Average | 76.04 |
| Relative Strength Index (RSI) | 32.46 |
| Average Volume (20 Days) | 2,390,068 |
Short Selling Information
The latest short interest is 5.92 million, so 2.64% of the outstanding shares have been sold short.
| Short Interest | 5.92M |
| Short Previous Month | 5.93M |
| Short % of Shares Out | 2.64% |
| Short % of Float | 2.66% |
| Short Ratio (days to cover) | 2.23 |
Income Statement
In the last 12 months, Hologic had revenue of $4.04 billion and earned $744.00 million in profits. Earnings per share was $3.16.
| Revenue | 4.04B |
| Gross Profit | 2.46B |
| Operating Income | 977.20M |
| Pretax Income | 789.10M |
| Net Income | 744.00M |
| EBITDA | 1.28B |
| EBIT | 977.20M |
| Earnings Per Share (EPS) | $3.16 |
Balance Sheet
The company has $1.98 billion in cash and $2.54 billion in debt, giving a net cash position of -$562.00 million or -$2.50 per share.
| Cash & Cash Equivalents | 1.98B |
| Total Debt | 2.54B |
| Net Cash | -562.00M |
| Net Cash Per Share | -$2.50 |
| Equity (Book Value) | 4.77B |
| Book Value Per Share | 21.16 |
| Working Capital | 2.49B |
Cash Flow
In the last 12 months, operating cash flow was $1.25 billion and capital expenditures -$123.80 million, giving a free cash flow of $1.13 billion.
| Operating Cash Flow | 1.25B |
| Capital Expenditures | -123.80M |
| Free Cash Flow | 1.13B |
| FCF Per Share | $5.04 |
Margins
Gross margin is 60.93%, with operating and profit margins of 24.19% and 18.42%.
| Gross Margin | 60.93% |
| Operating Margin | 24.19% |
| Pretax Margin | 22.81% |
| Profit Margin | 18.42% |
| EBITDA Margin | 31.67% |
| EBIT Margin | 24.19% |
| FCF Margin | 27.99% |
Dividends & Yields
Hologic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.48% |
| Shareholder Yield | 4.48% |
| Earnings Yield | 5.24% |
| FCF Yield | 7.96% |
Analyst Forecast
The average price target for Hologic is $85.42, which is 35.01% higher than the current price. The consensus rating is "Buy".
| Price Target | $85.42 |
| Price Target Difference | 35.01% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 4.85% |
| EPS Growth Forecast (5Y) | 10.30% |
Stock Splits
The last stock split was on April 3, 2008. It was a forward split with a ratio of 2:1.
| Last Split Date | Apr 3, 2008 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Hologic has an Altman Z-Score of 4.38 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.38 |
| Piotroski F-Score | 7 |